198 related articles for article (PubMed ID: 29975781)
1. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
[TBL] [Abstract][Full Text] [Related]
2. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
Bass AJ; Lawrence MS; Brace LE; Ramos AH; Drier Y; Cibulskis K; Sougnez C; Voet D; Saksena G; Sivachenko A; Jing R; Parkin M; Pugh T; Verhaak RG; Stransky N; Boutin AT; Barretina J; Solit DB; Vakiani E; Shao W; Mishina Y; Warmuth M; Jimenez J; Chiang DY; Signoretti S; Kaelin WG; Spardy N; Hahn WC; Hoshida Y; Ogino S; DePinho RA; Chin L; Garraway LA; Fuchs CS; Baselga J; Tabernero J; Gabriel S; Lander ES; Getz G; Meyerson M
Nat Genet; 2011 Sep; 43(10):964-968. PubMed ID: 21892161
[TBL] [Abstract][Full Text] [Related]
3. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer.
Lan F; Yue X; Han L; Shi Z; Yang Y; Pu P; Yao Z; Kang C
Int J Oncol; 2012 Feb; 40(2):519-26. PubMed ID: 21956205
[TBL] [Abstract][Full Text] [Related]
5. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants.
Nome T; Hoff AM; Bakken AC; Rognum TO; Nesbakken A; Skotheim RI
PLoS One; 2014; 9(3):e91264. PubMed ID: 24608966
[TBL] [Abstract][Full Text] [Related]
6. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CDX2 in the cross talk between TNF-α and Wnt signaling pathway in the colon cancer cell line Caco-2.
Coskun M; Olsen AK; Bzorek M; Holck S; Engel UH; Nielsen OH; Troelsen JT
Carcinogenesis; 2014 May; 35(5):1185-92. PubMed ID: 24501326
[TBL] [Abstract][Full Text] [Related]
8. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
9. Activation of Wnt/β-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression.
Wang N; Huo R; Cai B; Lu Y; Ye B; Li X; Li F; Xu H
Free Radic Biol Med; 2016 Jul; 96():34-44. PubMed ID: 27068063
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
Parr C; Mirzaei N; Christian M; Sastre M
FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of Cdx1 by oncogenic beta-catenin/Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein.
Domon-Dell C; Freund JN
FEBS Lett; 2002 May; 518(1-3):83-7. PubMed ID: 11997022
[TBL] [Abstract][Full Text] [Related]
13. Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells.
Olsen AK; Coskun M; Bzorek M; Kristensen MH; Danielsen ET; Jørgensen S; Olsen J; Engel U; Holck S; Troelsen JT
Carcinogenesis; 2013 Jun; 34(6):1361-9. PubMed ID: 23393221
[TBL] [Abstract][Full Text] [Related]
14. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
[TBL] [Abstract][Full Text] [Related]
15. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
16. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
[TBL] [Abstract][Full Text] [Related]
17. TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganization.
Brown MA; Dotson GA; Ronquist S; Emons G; Rajapakse I; Ried T
Neoplasia; 2021 Feb; 23(2):257-269. PubMed ID: 33422939
[TBL] [Abstract][Full Text] [Related]
18. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].
Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Inhibits Cell Viability and Increases Apoptosis of SW620 Human Colon Adenocarcinoma Cells via the Caudal Type Homeobox-2 (CDX2)/Wnt/β-Catenin Pathway.
Jiang X; Li S; Qiu X; Cong J; Zhou J; Miu W
Med Sci Monit; 2019 Oct; 25():7451-7458. PubMed ID: 31584928
[TBL] [Abstract][Full Text] [Related]
20. Cumulative evidence for relationships between multiple variants in the VTI1A and TCF7L2 genes and cancer incidence.
Zhang M; Tang M; Fang Y; Cui H; Chen S; Li J; Xiong H; Lu J; Gu D; Zhang B
Int J Cancer; 2018 Feb; 142(3):498-513. PubMed ID: 28949031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]